Artificial Kidney Global Market Report 2024

The artificial kidney market size has grown rapidly in recent years. It will grow from $9.22 billion in 2023 to $10.48 billion in 2024 at a compound annual growth rate (CAGR) of 13.7%. The growth in the historic period can be attributed to the increased prevalence of chronic kidney diseases (CKD), limited availability of donor organs, advancements in renal replacement therapies, improving the quality of life for end-stage renal disease (ESRD) patients, and the rise in the aging population.

The artificial kidney market size is expected to see rapid growth in the next few years. It will grow to $16.74 billion in 2028 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to rising healthcare investments and initiatives, patient preference for home-based therapies, and global efforts to reduce dialysis dependency. Major trends in the forecast period include the integration of sensors and monitoring devices, telehealth integration, focus on biocompatibility and immunogenicity, regulatory framework development, and global collaborations and research consortia.

The escalation in chronic kidney conditions is anticipated to drive the expansion of the artificial kidney sector in the forthcoming period. Chronic kidney disease, characterized by a gradual decline in kidney function, necessitates treatments such as artificial kidneys. These devices facilitate the elimination of waste products and toxins from the body, aiding in fluid retention and maintaining electrolyte balance. As reported by Kidney Research UK in June 2023, an estimated 7.19 million individuals in the UK were affected by chronic kidney disease, surpassing 10% of the population, with projections expecting a rise to 7.61 million by 2033. Consequently, the rising prevalence of chronic kidney diseases is a pivotal factor propelling growth in the artificial kidney market.

The burgeoning demand for kidney transplants is poised to propel the advancement of the artificial kidney industry. Kidney transplants involve the surgical implantation of a healthy donor kidney into an individual whose own kidneys are failing. Artificial kidneys, serving as interim solutions, offer a promising alternative while awaiting a suitable donor for a traditional transplant. This transition could substantially enhance the quality of life for recipients and alleviate the burdens of undergoing dialysis. According to the Health Resources and Services Administration in 2021, the count of adults awaiting kidney transplants surged by 11.6%, rising from 37,399 in 2020 to 41,765 in 2021. Hence, the escalating demand for kidney transplants is a driving force behind the growth of the artificial kidney market.

Technological advancements represent a prominent trend surging within the artificial kidney sector. Key market players are actively introducing cutting-edge products to fortify their market stance. An illustration of this trend is observed in NephroPlus' Renova, launched in July 2022. This innovative dialyzer reprocessing system, equipped with cloud storage, stands as a testament to such progress. Renova, a cloud-connected device, empowers biomedical engineers to troubleshoot issues remotely, utilizing cloud-based connectivity. Through the Renova app, engineers gain access to real-time status updates, including detailed operations analysis, facilitating precise diagnostics and swift resolutions. The dialyzer, integral to this system, plays a pivotal role in mitigating infection risks, enhancing dialysis quality, and proficiently purging toxins from the blood, compensating for the kidneys' diminished function.

Major entities within the artificial kidney sphere are heavily invested in crafting innovative solutions, notably portable hemodialysis devices. An exemplar in this realm is Nextkidney's Neokidney, announced in November 2022. This portable hemodialysis device, compact and user-friendly, redefines accessibility by enabling patients to undergo dialysis in the comfort of their homes or any location with electricity. The Neokidney's operational efficiency, requiring merely 7 liters of water per treatment, significantly mitigates logistical complexities and wastage. Facilitating more frequent and shorter-duration dialysis sessions, this device holds promise in potentially ameliorating overall health outcomes for patients.

In April 2023, M42, a tech-enabled healthcare company based in the United Arab Emirates, successfully acquired Diaverum for an undisclosed sum from Bridgepoint. This strategic acquisition positions M42 to extend its footprint in the healthcare sector, introduce innovative solutions to a global patient base, and leverage Diaverum's extensive network of clinics and patients specializing in dialysis services.

Major companies operating in the artificial kidney market report are Fresenius SE And Co. KGaA, Medtronic Plc., Asahi Kasei Medical Co. Ltd., Toray Industries Inc., Baxter International Inc., DaVita Inc., B. Braun Melsungen AG, UCLA Health, Revvity, Nipro Medical Corporation, Nikkiso Co. Ltd., Merit Medical Systems Inc., Kawasumi Laboratories Inc., Quanta Dialysis Technologies Ltd., Triomed AB, Advent Access, WearOptimo, AWAK Technologies Pvt. Ltd., Aethlon Medical Inc., Blood Purification Technologies Inc., Xcorporeal Inc., Nanodialysis B.V, Neokidney Development BV, Wearable Medical Devices Inc., Nephria Bio Inc., US Kidney Research Corporation.

North America was the largest region in the artificial kidney market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial kidney market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the artificial kidney market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary categories of artificial kidneys include wearable artificial kidneys and implantable artificial kidneys. Wearable artificial kidneys are portable devices worn by patients to simulate the functions of a natural kidney. This category encompasses methods such as hemodialysis, peritoneal dialysis, and combination approaches. The main end-users of artificial kidneys include hospitals, specialty clinics, ambulatory surgical centers, and other medical facilities.

The artificial kidney market research report is one of a series of new reports that provides artificial kidney market statistics, including artificial kidney industry global market size, regional shares, competitors with an artificial kidney market share, detailed artificial kidney market segments, market trends and opportunities, and any further data you may need to thrive in the artificial kidney industry. This artificial kidney market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial kidney market consists of sales of peritoneal dialysis systems, hemodialysis artificial kidneys, dialysis membranes, filtration systems, pumping systems, bioartificial kidneys, dialysate compartments, and semipermeable hollow fibers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.